Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2011, Article ID 548140, 8 pages
http://dx.doi.org/10.1155/2011/548140
Research Article

Roles of Adiponectin and Oxidative Stress in the Regulation of Membrane Microviscosity of Red Blood Cells in Hypertensive Men—An Electron Spin Resonance Study

1Cardiovascular and Metabolic Research Center, Kansai University of Health Sciences, Senn-nann-gunn, Kumatori-cho, Wakaba 2-11-1, Osaka 590-0482, Japan
2Division of Cardiology, Department of Medicine, Wakayama Medical University, Wakayama 641-8509, Japan

Received 27 May 2010; Accepted 18 July 2010

Academic Editor: S. B. Heymsfield

Copyright © 2011 Kazushi Tsuda. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kumada, S. Kihara, S. Sumitsuji et al., “Association of hypoadiponectinemia with coronary artery disease in men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 1, pp. 85–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Ouchi, M. Ohishi, S. Kihara et al., “Association of hypoadiponectinemia with impaired vasoreactivity,” Hypertension, vol. 42, no. 3, pp. 231–234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Adamczak, A. Wiecek, T. Funahashi, J. Chudek, F. Kokot, and Y. Matsuzawa, “Decreased plasma adiponectin concentration in patients with essential hypertension,” American Journal of Hypertension, vol. 16, no. 1, pp. 72–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Iwashima, T. Katsuya, K. Ishikawa et al., “Hypoadiponectinemia is an independent risk factor for hypertension,” Hypertension, vol. 43, no. 6, pp. 1318–1323, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Furuhashi, N. Ura, K. Higashiura et al., “Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension,” Hypertension, vol. 42, no. 1, pp. 76–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Ceriello, “Possible role of oxidative stress in the pathogenesis of hypertension,” Diabetes Care, vol. 31, supplement 2, pp. S181–184, 2008. View at Google Scholar · View at Scopus
  7. A. A. Elesber, P. J. Best, R. J. Lennon et al., “Plasma 8-iso-prostaglandin F2α, a marker of oxidative stress, is increased in patients with acute myocardial infarction,” Free Radical Research, vol. 40, no. 4, pp. 385–391, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Cangemi, F. Angelico, L. Loffredo et al., “Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid,” Free Radical Biology and Medicine, vol. 43, no. 5, pp. 853–859, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Dhawan and S. Jain, “Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension,” Molecular and Cellular Biochemistry, vol. 266, no. 1-2, pp. 109–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Rodrigo, H. Prat, W. Passalacqua, J. Araya, C. Guichard, and J. P. Bächler, “Relationship between oxidative stress and essential hypertension,” Hypertension Research, vol. 30, no. 12, pp. 1159–1167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Vassalle, N. Botto, M. G. Andreassi, S. Berti, and A. Biagini, “Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease,” Coronary Artery Disease, vol. 14, no. 3, pp. 213–218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Wang, J. Pan, L. Wang, H. Zhu, R. Yu, and Y. Zou, “Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease,” Atherosclerosis, vol. 184, no. 2, pp. 425–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. W. H. F. Sutherland, P. J. Manning, R. J. Walker, S. A. De Jong, A. R. Ryalls, and E. A. Berry, “Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects,” Obesity, vol. 15, no. 2, pp. 386–391, 2007. View at Google Scholar · View at Scopus
  14. J. A. Panza, A. A. Quyyumi, J. E. Brush Jr., and S. E. Epstein, “Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension,” New England Journal of Medicine, vol. 323, no. 1, pp. 22–27, 1990. View at Google Scholar · View at Scopus
  15. K. Node, M. Kitakaze, H. Yoshikawa, H. Kosaka, and M. Hori, “Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension,” Hypertension, vol. 30, no. 3 I, pp. 405–408, 1997. View at Google Scholar · View at Scopus
  16. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M. J. Quon, “Adiponectin stimulates production of nitric oxide in vascular endothelial cells,” Journal of Biological Chemistry, vol. 278, no. 45, pp. 45021–45026, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. K. C. B. Tan, A. Xu, W. S. Chow et al., “Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 765–769, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Loffredo, A. Marcoccia, P. Pignatelli et al., “Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease,” European Heart Journal, vol. 28, no. 5, pp. 608–612, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Annuk, M. Zilmer, L. Lind, T. Linde, and B. Fellström, “Oxidative stress and endothelial function in chronic renal failure,” Journal of the American Society of Nephrology, vol. 12, no. 12, pp. 2747–2752, 2001. View at Google Scholar · View at Scopus
  20. Y. Yamori, Y. Nara, R. Horie, and A. Ooshima, “Abnormal membrane characteristics of erythrocytes in rat models and men with predisposition to stroke,” Clinical and Experimental Hypertension, vol. 2, no. 6, pp. 1009–1021, 1980. View at Google Scholar · View at Scopus
  21. K. Tsuda and I. Nishio, “Membrane fluidity and hypertension,” American Journal of Hypertension, vol. 16, no. 3, pp. 259–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Zicha, J. Kuneš, and M.-A. Devynck, “Abnormalities of membrane function and lipid metabolism in hypertension,” American Journal of Hypertension, vol. 12, no. 3, pp. 315–331, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Tsuda, H. Iwahashi, and Y. Minatogawa, “Electron spin resonance studies of erythrocytes from spontaneously hypertensive rats and humans with essential hypertension,” Hypertension, vol. 9, no. 6, pp. 19–24, 1987. View at Google Scholar · View at Scopus
  24. K. Tsuda, Y. Kinoshita, K. Kimura, I. Nishio, and Y. Masuyama, “Electron paramagnetic resonance investigation on modulatory effect of 17β-estradiol on membrane fluidity of erythrocytes in postmenopausal women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 8, pp. 1306–1312, 2001. View at Google Scholar · View at Scopus
  25. K. Tsuda and I. Nishio, “A selective estrogen receptor modulator, tamoxifen, and membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women: an electron paramagnetic resonance investigation,” American Journal of Hypertension, vol. 18, no. 8, pp. 1067–1076, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Tsuda, “Electron paramagnetic resonance investigation on modulatory effect of benidipine on membrane fluidity of erythrocytes in essential hypertension,” Heart and Vessels, vol. 23, no. 2, pp. 134–139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Tsuda, “Adiponectin and membrane fluidity of erythrocytes in normotensive and hypertensive men,” Obesity, vol. 14, no. 9, pp. 1505–1510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Tsuda, “Oxidative stress and membrane fluidity of red blood cells in hypertensive and normotensive men: an electron Spin resonance investigation,” International Heart Journal, vol. 51, no. 2, pp. 121–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Muriel and G. Sandoval, “Nitric oxide and peroxynitrite anion modulate liver plasma membrane fluidity and Na+/K+-ATPase activity,” Nitric Oxide, vol. 4, no. 4, pp. 333–342, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Tsuda, K. Kimura, I. Nishio, and Y. Masuyama, “Nitric oxide improves membrane fluidity of erythrocytes in essential hypertension: an electron paramagnetic resonance investigation,” Biochemical and Biophysical Research Communications, vol. 275, no. 3, pp. 946–954, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Tsuda, Y. Kinoshita-Shimamoto, K. Kimura, and I. Nishio, “Nitric oxide is a determinant of membrane fluidity of erythrocytes in postmenopausal women: an electron paramagnetic resonance investigation,” American Journal of Hypertension, vol. 16, no. 3, pp. 244–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. K.-H. Le Quan Sang, J. Levenson, M. Del Pino, A. Simon, and M.-A. Devynck, “In vivo shear flow and erythrocyte membrane fluidity in hypertensive patients,” British Journal of Clinical Pharmacology, vol. 36, no. 5, pp. 437–443, 1993. View at Google Scholar · View at Scopus
  33. C. Saldanha, L. Sargenter, J. Monteiro, C. Perdigão, C. Ribeiro, and J. Martins-Silva, “Impairment of the erythrocyte membrane fluidity in survivors of acute myocardial infarction. A prospective study,” Clinical Hemorheology and Microcirculation, vol. 20, no. 2, pp. 111–116, 1999. View at Google Scholar · View at Scopus
  34. R. Cazzola, M. Rondanelli, S. Russo-Volpe, E. Ferrari, and B. Cestaro, “Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes,” Journal of Lipid Research, vol. 45, no. 10, pp. 1846–1851, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. A. G. Lee, “Lipid-protein interactions in biological membranes: a structural perspective,” Biochimica et Biophysica Acta, vol. 1612, no. 1, pp. 1–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. P. K. J. Kinnunen, A. Kõiv, J. Y. A. Lehtonen, M. Rytömaa, and P. Mustonen, “Lipid dynamics and peripheral interactions of proteins with membrane surfaces,” Chemistry and Physics of Lipids, vol. 73, no. 1-2, pp. 181–207, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. C.-G. Zou, N. S. Agar, and G. L. Jones, “Oxidative insult to human red blood cells induced by free radical initiator AAPH and its inhibition by a commercial antioxidant mixture,” Life Sciences, vol. 69, no. 1, pp. 75–86, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Lenfant, J. J. Lahet, C. Vergely, F. Volot, M. Freysz, and L. Rochette, “Lidocaine inhibits potassium efflux and hemolysis in erythrocytes during oxidative stress in vitro,” General Pharmacology, vol. 34, no. 3, pp. 193–199, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. B. C. Jubelin and J. L. Gierman, “Erythrocyte may synthesize their own nitric oxide,” American Journal of Hypertension, vol. 9, no. 12 I, pp. 1214–1219, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Y. Chen and J. L. Mehta, “Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function,” Journal of Cardiovascular Pharmacology, vol. 32, no. 1, pp. 57–61, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Xu, H. Wang, R. L. C. Hoo et al., “Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice,” Endocrinology, vol. 150, no. 2, pp. 625–633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Kondo, R. Shibata, K. Unno et al., “Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model,” Circulation: Cardiovascular Interventions, vol. 3, no. 2, pp. 166–173, 2010. View at Publisher · View at Google Scholar · View at Scopus